UBS Group’s Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant FACA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-811
Closed -$8K 11572
2022
Q3
$8K Sell
811
-849
-51% -$8.37K ﹤0.01% 8813
2022
Q2
$16K Sell
1,660
-1,295
-44% -$12.8K ﹤0.01% 7251
2022
Q1
$29K Buy
2,955
+1,474
+100% +$14.7K ﹤0.01% 7052
2021
Q4
$15K Buy
1,481
+256
+21% +$2.59K ﹤0.01% 8296
2021
Q3
$12K Sell
1,225
-1,842
-60% -$18.6K ﹤0.01% 7831
2021
Q2
$32K Buy
+3,067
New +$31.7K ﹤0.01% 6868

UBS Group's FACA.U Position: Q4 2022 in Review

UBS Group sold out of Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant (FACA.U) in Q4 2022, closing a stake of 811 shares — an estimated $8K sold.

UBS Group first reported a position in FACA.U in Q2 2021 and held it in 6 quarters. The position peaked at $32K in Q2 2021. 0 funds tracked by Wall St. Rank hold FACA.U as of Q4 2022.

  • UBS Group reported no remaining Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 811 Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant shares in Q4 2022, an estimated $8K.
  • UBS Group first reported a position in Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant in Q2 2021 and held it in 6 quarters.
  • UBS Group's Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position peaked at $32K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.